Results 141 to 150 of about 61,873 (283)
ESC Heart Failure, EarlyView.Abstract Right ventricular failure (RVF) is a common complication following left ventricular assist device (LVAD) implantation and increases patient morbidity and mortality. Due to the complex and limited understanding of RVF pathophysiology, efforts to prognosticate RVF after LVAD have been challenging.
Abdul‐Fatawu Osman +11 more
wiley +1 more source
Linchuang shenzangbing zazhi, 2019 Objective To analyze the significance N-terminal pro-brain natriuretic peptide(NT-proBNP) decline in evaluation of heart failure during hemodialysis in patients with maintenance hemodialysis(MHD). Methods The level of NT-proBNP and ultrafiltration at 0 h,
LI Ping, YUAN Xiao-ying, XIAO Ying
doaj
Cilostazol in patients with heart failure and preserved ejection fraction—The CLIP‐HFpEF trial
ESC Heart Failure, Volume 12, Issue 2, Page 1437-1446, April 2025.• Cilostazol is an oral PDE‐3 inhibitor that may have advantageous effects in heart failure with preserved ejection fraction (HFpEF). • Cilostazol significantly improved short‐term heart failure‐related health status scores (KCCQ‐12) and NT‐proBNP levels when compared to placebo.
Norman Aiad +9 more
wiley +1 more source
THE EFFECTS OF HYPERTENSION STAGES ON N-TERMINAL-PRO BRAIN NATRIURETIC PEPTIDE (NT-PRO-BNP) LEVEL AND LEFT VENTRICULAR EJECTION FRACTION [PDF]
, 2019 Introduction: Hypertension is the most common risk factor for heart failure causing an increase in N-Terminal-Pro Brain Natriuretic Peptide (NT-proBNP) level and a decrease in left ventricular ejection fraction (LVEF).
Abduh, M. Saugi +2 more
core
Genel Tıp Dergisi, 2019 Amaç: Romatoid artrit RA ’te kardiyovasküler komplikasyonlar sık ortaya çıkmaktadır. Bu komplikasyonlar arasında perikardit, miyokardit, kardiyak amiloidoz, koroner vaskülit, aritmi ve kapak hastalığı olduğu gibi konjestif kalp yetmezliği ve iskemik ...
Bülent Bütün +2 more
doaj
ESC Heart Failure, EarlyView.AIM This analysis provides a comparison of the efficacy of initial mono and combination therapy in patients with PAH and cardiovascular comorbidities or with risk factors of HFpEF (heart failure with preserved ejection fractioin).METHOD Data from the European COMPERA registry were used for a matched pair analysis.
Dirk Skowasch +20 more
wiley +1 more source
Quantum dot enabled lateral flow immunoassay for detection of cardiac biomarker NT-proBNP
Sensing and Bio-Sensing Research, 2018 B-type natriuretic peptide (BNP) is a cardiac-derived neurohormone regulated by intra-cardiac pressure. N-terminal pro-B-type natriuretic peptide (NT-proBNP) is a bio-inert product of BNP production identified as a blood biomarker for diagnosing cardiac ...
Michael D. Wilkins +4 more
doaj
ESC Heart Failure, EarlyView.Abstract Aims Information about current use of finerenone in patients with heart failure (HF) finerenone in clinical practice is scarce, and its effectiveness in clinical practice in patients is scarce. We aim to assess both the baseline clinical profile and prognostic role of finerenone in patients with HF, irrespective of ejection fraction.
Gonzalo Luis Alonso Salinas +32 more
wiley +1 more source
Journal of the American College of Cardiology, 2016 John C. Burnett, Paul M. McKie
openaire +2 more sources